References
- Almeida J, Orfao A, Mateo G, . Immunophenotypic and DNA content characteristics of plasma cells in multiple myeloma and monoclonal gammopathy of undetermined significance. Pathol Biol (Paris) 1999;47:119–127.
- Mateo G, Castellanos M, Rasillo A, . Genetic abnormalities and patterns of antigenic expression in multiple myeloma. Clin Cancer Res 2005;11:3661–3667.
- Pozdnyakova O, Morgan EA, Li B, . Patterns of expression of CD56 and CD117 on neoplastic plasma cells and association with genetically distinct subtypes of plasma cell myeloma. Leuk Lymphoma 2012;53:1905–1910
- Menu E, Asosingh K, Indraccolo S, . The involvement of stromal derived factor 1alpha in homing and progression of multiple myeloma in the 5TMM model. Haematologica 2006;91:605–612.
- Gupta D, Treon SP, Shima Y, . Adherence of multiple myeloma cells to bone marrow stromal cells upregulates vascular endothelial growth factor secretion: therapeutic applications. Leukemia 2001;15: 1950–1961.
- Vande Broek I, Vanderkerken K, Van Camp B, . Extravasation and homing mechanisms in multiple myeloma. Clin Exp Metastasis 2008;25:325–334.
- Blade J, Fernandez de LC, Rosinol L, . Soft-tissue plasmacytomas in multiple myeloma: incidence, mechanisms of extramedullary spread, and treatment approach. J Clin Oncol 2011;29: 3805–3812.
- Mateo G, Montalban MA, Vidriales MB, . Prognostic value of immunophenotyping in multiple myeloma: a study by the PETHEMA/GEM cooperative study groups on patients uniformly treated with high-dose therapy. J Clin Oncol 2008;26: 2737–2744.